Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)

Historical Holders from Q3 2023 to Q3 2025

Symbol: SGMT on Nasdaq
Type / Class: Equity / Series A Common Stock, $0.0001 par value per share
Shares outstanding: 31,278,271
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 12,635,689
Holdings value: $86,680,189
% of all portfolios: 0%
Number of holders: 72
Number of buys: 41
Number of sells: -25
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AP11 Ltd	4.9%	-10%	$5,055,597	-$504,198	1,504,642	-9.1%	AP11 Limited	24 Jun 2025
Woodline Partners LP	4.8%	-43.8%	$10,299,309	-$7,211,088	1,501,357	-41.2%	Woodline Partners LP	30 Sep 2025
Blue Owl Capital Holdings LP	4.32%		$4,527,659		1,323,877		Blue Owl Capital Holdings LP	31 Dec 2024

Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	12,635,689	$86,680,189	+$6,909,222	$1,207,360	$1,766,078	$6.86	72
2025 Q2	11,676,267	$88,988,335	+$3,493,936	$2,105,406	$2,979,420	$7.62	67
2025 Q1	13,776,513	$44,920,783	-$15,209,275	$378,160	$307,440	$3.26	69
2024 Q4	17,500,774	$78,763,978	-$8,862,770	$1,097,100	$242,550	$4.5	66
2024 Q3	19,656,790	$54,446,688	-$7,224,186	$435,998	$205,811	$2.77	63
2024 Q2	20,925,200	$71,568,836	-$7,461,714	$28,044	$3,420	$3.42	81
2024 Q1	22,609,183	$122,544,913	+$44,339,223			$5.42	81
2023 Q4	14,445,035	$76,118,157	-$8,948,267			$5.42	51
2023 Q3	11,717,467	$103,113,019	+$103,113,019			$8.8	47